Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer

Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer

The mainstay treatment for patients with immediate resectable pancreatic cancer remains upfront surgery, which represents the only potentially curative strategy. Nevertheless, the majority of patients surgically resected for pancreatic cancer experiences disease relapse, even when a combination adju...

Full description

Bibliographic Details
Main Authors:	Valeria Merz, Domenico Mangiameli, Camilla Zecchetto, Alberto Quinzii, Silvia Pietrobono, Carlo Messina, Simona Casalino, Marina Gaule, Camilla Pesoni, Pasquale Vitale, Chiara Trentin, Michela Frisinghelli, Orazio Caffo, Davide Melisi
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Surgery
Subjects:	resectable pancreatic cancer predictive factors neoadjuvant therapy preoperative treatment target therapy molecular profiling
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2022.866173/full

Similar Items

Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear
by: Davide Melisi, et al.
Published: (2024-04-01)

Targeting KRAS: The Elephant in the Room of Epithelial Cancers
by: Valeria Merz, et al.
Published: (2021-03-01)

Multicenter Retrospective Analysis of Second-Line Therapy after Gemcitabine Plus Nab-Paclitaxel in Advanced Pancreatic Cancer Patients
by: Valeria Merz, et al.
Published: (2020-04-01)

Targeting FGFR Pathway Is Not an Effective Therapeutic Strategy in Patients with Unselected Metastatic Esophagogastric Cancer Resistant to Trastuzumab
by: Camilla Zecchetto, et al.
Published: (2023-03-01)

YAP Activation Is Associated with a Worse Prognosis of Poorly Cohesive Gastric Cancer
by: Maria Bencivenga, et al.
Published: (2023-08-01)

The Multifaceted Role of TGF-β in Gastrointestinal Tumors
by: Fabio Sabbadini, et al.
Published: (2021-08-01)

Cancer nanomedicine in preoperative therapeutics: Nanotechnology-enabled neoadjuvant chemotherapy, radiotherapy, immunotherapy, and phototherapy
by: Xiaogang Qu, et al.
Published: (2023-06-01)

Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges
by: Sukumar Kalvapudi, et al.
Published: (2023-12-01)

Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center
by: Naoki Mita, et al.
Published: (2021-06-01)

Oncological outcomes of visibly complete transurethral resection prior to neoadjuvant chemotherapy for bladder cancer
by: Bryce Baird, et al.
Published: (2023-08-01)

Treatment of primary and secondary liver malignancy
by: Z Kadry, et al.
Published: (2001-06-01)

Pre-operative vs. post-operative stereotactic radiosurgery for operative metastatic brain tumors: study protocol for a phase III clinical trial
by: David M. Routman, et al.
Published: (2024-03-01)

The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy
by: Hironobu Suto, et al.
Published: (2019-12-01)

Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study
by: Israa Imam, et al.
Published: (2023-02-01)

Induction chemotherapy, chemoradiotherapy and consolidation chemotherapy in preoperative treatment of rectal cancer - long-term results of phase II OIGIT-01 Trial
by: Golo Danijela, et al.
Published: (2018-09-01)

Pattern of Residual Submucosal Involvement after Neoadjuvant Therapy for Rectal Cancer: A Rationale for the Utility of Endoscopic Submucosal Resection
by: Haidy Elazzamy, et al.
Published: (2023-10-01)

Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers
by: Alessandro Olivari, et al.
Published: (2023-07-01)

Perception versus reality: A National Cohort Analysis of the surgery‐first approach for resectable pancreatic cancer
by: John R. Bergquist, et al.
Published: (2021-09-01)

Changes in Oncological Surgical Principles Driven by Advances in Preoperative Treatments
by: Horváth ÖP, et al.
Published: (2023-08-01)

Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma
by: Anish J. Jain, et al.
Published: (2023-08-01)

Study protocol: Randomized, open-label, non-inferiority clinical trial for evaluating the clinical and pathological response rates to neoadjuvant hormone therapy and chemotherapy in patients with luminal-subtype breast tumors
by: Maria Carolina Gouveia, et al.
Published: (2022-12-01)

HOX Genes Family and Cancer: A Novel Role for Homeobox B9 in the Resistance to Anti-Angiogenic Therapies
by: Serena Contarelli, et al.
Published: (2020-11-01)

Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?
by: Nathalie Rosumeck, et al.
Published: (2021-01-01)

Intraoperative Radiation “Boost” to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A Case Report
by: Tarita O. Thomas, et al.
Published: (2018-03-01)

Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis
by: Hesong Wang, et al.
Published: (2023-05-01)

Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer
by: Akiyuki Wakita, et al.
Published: (2023-11-01)

Radical Resection for Locally Advanced Pancreatic Cancers in the Era of New Neoadjuvant Therapy—Arterial Resection, Arterial Divestment and Total Pancreatectomy
by: Yosuke Inoue, et al.
Published: (2021-04-01)

Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study
by: Stefan Heinrich, et al.
Published: (2019-07-01)

Induction Strategy for Locally Advanced Thymoma
by: Yang Zhang, et al.
Published: (2021-07-01)

The Combination of Neoadjuvant Therapy and Surgical Resection: A Safe and Effective Treatment for Rectal Gastrointestinal Stromal Tumors
by: Liu Y, et al.
Published: (2021-06-01)

The Role of Preoperative Chemotherapy in the Management of Synchronous Resectable Colorectal Liver Metastases: A Meta-Analysis
by: Kostas Tepelenis, et al.
Published: (2023-04-01)

A Novel atTAK Against Hepatocellular Carcinoma: Overcoming Resistance to Sorafenib
by: Silvia Pietrobono, MD, et al.
Published: (2021-01-01)

Preoperative oncologic therapy and the prolonged risk of venous thromboembolism in resectable pancreatic cancer
by: Annika Eurola, et al.
Published: (2022-04-01)

Treatment of Intrahepatic Cholangiocarcinoma—A Multidisciplinary Approach
by: Felix Krenzien, et al.
Published: (2022-01-01)

Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with <sup>90</sup>Y-Microspheres: A Systematic Review
by: Emrullah Birgin, et al.
Published: (2020-01-01)

Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature
by: Mitsuru Kinoshita, et al.
Published: (2022-09-01)

How A Patient with Resectable or Borderline Resectable Pancreatic Cancer should Be Treated—A Comprehensive Review
by: Daria Kwaśniewska, et al.
Published: (2023-08-01)

Preoperative Radio(Chemo)Therapy in Breast Cancer: Time to Switch the Perspective?
by: Angel Montero, et al.
Published: (2022-12-01)

Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
by: Tarun Kumar, et al.
Published: (2020-03-01)

Treatment Outcome of External Auditory Canal Carcinoma: The Utility of Lateral Temporal Bone Resection
by: Kohei Saijo, et al.
Published: (2021-08-01)